相关实验视频

Updated: Jun 12, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

重新思考免疫检查点抑制剂在肝移植中的使用:影响和抵抗

Vivian Ortiz¹, Emilien Loeuillard²

¹Division of Gastroenterology, Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, Missouri.

Cellular and molecular gastroenterology and hepatology

|September 26, 2024

概括

免疫检查点抑制剂 (ICI) 提供了癌症治疗的进步,但在肝移植过程中带来了挑战. 本综述探讨了它们的复杂作用,重点关注肝癌患者的瘤抵抗性和移植存活率.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
移植医学移植医学

背景情况:

免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,包括肝癌,如肝细胞癌和胆管癌.
然而,由于它们对免疫耐受性和移植生存的潜在影响,它们在肝移植周围的应用受到争论.

研究的目的:

审查目前在肝移植的背景下ICI的使用情况.
分析ICI对肝脏瘤移植患者免疫耐受性和耐药性的影响.
探索用于组合或连续治疗的新型治疗策略.

主要方法:

对肝癌和移植中免疫检查点抑制剂的研究进行文献综述.
对瘤免疫逃避和ICI抵抗机制的分析.
检查ICI对T细胞群和移植免疫学的影响.

主要成果:

由于促进ICI耐药性的免疫逃避机制,瘤复发是频繁的.
通过影响记忆T细胞和诱导炎症,ICI可以对移植耐受性和生存产生负面影响.
ICI和免疫抑制之间的相互作用对于管理瘤负担至关重要.

结论:

在肝脏瘤的移植前期使用ICI需要仔细考虑,因为可能导致移植体排斥和瘤耐药性.
可能需要采用多模式治疗方法,可能将ICI与其他治疗方法结合起来.
对优化肝移植患者ICI治疗的进一步研究是有必要的.

关键词:

胆性瘤是一种胆性瘤.肝细胞癌肝细胞癌免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.肝脏移植肝脏移植电阻电阻电阻电阻电阻电阻宽容是一种宽容.

更多相关视频

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

相关概念视频

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...